Skip to content
BCI.INTEL
NLINKN1 Chip+PRIME.StudySYNCRStentrode+$200M.SeriesDPRECNLayer 7+FDA.BrkthruPARAMArgo+$20M.SeriesBBLKRKNeuroport+200.ImplantsEMTIVMN8+$45M.SeriesBKRNLFlux+Non-invasiveNRBLEHalo+Consumer.BCINEURONeuroPace+RNS.SystemCOGNICognixion+ALS.TrialFUND.YTD2026$2.8B.SectorTRIALSActive50+.ClinTrialsIMPLNTSHumans~100.Intracrtnl
Terminal/Companies/Precision Neuroscience
activeFounded 2021

Precision Neuroscience

HQ: New York, NY, USACEO: Michael MagerHeadcount: ~117www.precisionneuro.io
Funding Summary
Total Funding
$183M
Latest Valuation
$500M (2024 Series C)
About

Precision Neuroscience was founded by Benjamin Rapoport, Michael Mager, and Mark Hettick, with Rapoport and Mager both veterans of Neuralink. The company's Layer 7 Cortical Interface is a 1,024-electrode ECoG array delivered via a minimally invasive slit craniotomy — a strategic bet on surface recording rather than penetrating intracortical arrays. The Layer 7 received FDA 510(k) clearance in 2025 for implantation durations of up to 30 days. Precision has implanted Layer 7 on the cerebral cortex of 37+ patients as of April 2025 and announced a partnership with Medtronic to integrate Layer 7 with the StealthStation surgical navigation system in January 2026.

Products
precision-layer-7
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →
Referenced In